Multi-formed collagenous biomaterial medical device
The invention involves a submucosa tissue that has the capability of being shape formed or shape configured. The submucosa involves a purified form of submucosa tissue. Optionally, the submucosa can be packaged in such a manner to permit sterility or maintain sterility of the submucosa.
1. A collagenous biomaterial medical device comprising a collagenous biomaterial isolated as a sheet of tissue from a source tissue of a urinary tract of a mammal and retaining a collagen biomaterial structure including collagen biomaterial from tissue mucosa and tissue submucosa layers of the source tissue, wherein the tissue submucosa has been separated from attached tunica muscularis tissue of the source tissue and substantially retains an inherent biochemistry from the source tissue, wherein said isolated collagenous biomaterial further comprises a growth factor and exhibits the capacity to remodel tissue upon implant in a patient, and wherein said isolated collagenous biomaterial has a nucleic acid content of less than 10 micrograms per milligram and a bioburden of less than 1 colony forming unit per gram.
2. The medical device of claim 1 , wherein said collagenous biomaterial is in lyophilized form.
3. The medical device of claim 1 also comprising at least one pharmacologic agent added to the collagenous biomaterial.
4. The medical device of claim 1 wherein the collagenous biomaterial is crosslinked with a crosslinking agent.
5. The medical device of claim 1 wherein the collagenous biomaterial has not been crosslinked with a crosslinking agent.
6. The medical device of claim 4 wherein the crosslinking agent is glutaraldehyde.
7. The medical device of claim 1 wherein the collagenous biomaterial has a nucleic acid level of less than 5 micrograms per milligram.
8. The medical device of claim 1 wherein the collagenous biomaterial has a bioburden of less than 0.5 colony forming units per gram.
9. The medical device of claim 1 , wherein said collagenous biomaterial is in lyophilized form, and also comprising a sterile double pouch package enclosing said collagenous biomaterial.
10. The medical device of claim 1 , wherein said source tissue is urinary bladder.
11. The medical device of claim 10 , wherein said source tissue is porcine.
12. The medical device of claim 1 , wherein said collagenous biomaterial is in sheet form.
13. The medical device of claim 1 , wherein said collagenous biomaterial is in sponge form.
14. A collagenous biomaterial medical device, comprising: a collagenous biomaterial isolated as a sheet of tissue from urinary tract tissue of a mammal and retaining a collagen biomaterial structure including collagen biomaterial from layers of tissue mucosa and collagen-containing connective tissue occurring under the tissue mucosa in the urinary tract tissue, wherein the collagen-containing connective tissue has been separated from attached tunica muscularis tissue of the urinary tract tissue, wherein said isolated collagenous biomaterial further comprises a growth factor and exhibits the capacity to remodel tissue upon implant into a patient, and wherein said isolated collagenous biomaterial has a nucleic acid content of less than 10 micrograms per milligram and a bioburden of less than 2 colony forming units per gram.
15. The medical device of claim 14 , wherein the urinary tract tissue is urinary bladder tissue.
16. The medical device of claim 14 , wherein the collagenous biomaterial has a nucleic acid content of less than 5 micrograms per gram.
17. The medical device of claim 14 , wherein the collagenous biomaterial is in lyophilized form.
18. The medical device of claim 14 , wherein the collagenous biomaterial has not been crosslinked with a crosslinking agent.
19. The medical device of claim 14 , wherein the mammal is a pig.
20. The medical device of claim 19 , wherein the urinary tract tissue is urinary bladder tissue.